285 related articles for article (PubMed ID: 19441017)
1. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.
Xu T; Zhu Y; Xiong Y; Ge YY; Yun JP; Zhuang SM
Hepatology; 2009 Jul; 50(1):113-21. PubMed ID: 19441017
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.
Xiao F; Zhang W; Chen L; Chen F; Xie H; Xing C; Yu X; Ding S; Chen K; Guo H; Cheng J; Zheng S; Zhou L
J Transl Med; 2013 Aug; 11():195. PubMed ID: 23967867
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM
Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302
[TBL] [Abstract][Full Text] [Related]
4. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.
Xiong Y; Fang JH; Yun JP; Yang J; Zhang Y; Jia WH; Zhuang SM
Hepatology; 2010 Mar; 51(3):836-45. PubMed ID: 20041405
[TBL] [Abstract][Full Text] [Related]
5. miRNA-302b suppresses human hepatocellular carcinoma by targeting AKT2.
Wang L; Yao J; Zhang X; Guo B; Le X; Cubberly M; Li Z; Nan K; Song T; Huang C
Mol Cancer Res; 2014 Feb; 12(2):190-202. PubMed ID: 24337067
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
Huang L; Luo J; Cai Q; Pan Q; Zeng H; Guo Z; Dong W; Huang J; Lin T
Int J Cancer; 2011 Apr; 128(8):1758-69. PubMed ID: 20549700
[TBL] [Abstract][Full Text] [Related]
8. miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6.
Zhu H; Wang G; Zhou X; Song X; Gao H; Ma C; Chang H; Li H; Liu FF; Lu J; Ma J
Biomed Pharmacother; 2016 Oct; 83():792-797. PubMed ID: 27490780
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
Cheng J; Wu LM; Deng XS; Wu J; Lv Z; Zhao HF; Yang Z; Ni Y
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):336-344. PubMed ID: 30108016
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma.
Bae HJ; Noh JH; Kim JK; Eun JW; Jung KH; Kim MG; Chang YG; Shen Q; Kim SJ; Park WS; Lee JY; Nam SW
Oncogene; 2014 May; 33(20):2557-67. PubMed ID: 23728341
[TBL] [Abstract][Full Text] [Related]
11. miR-363 inhibits the growth, migration and invasion of hepatocellular carcinoma cells by regulating E2F3.
Ye J; Zhang W; Liu S; Liu Y; Liu K
Oncol Rep; 2017 Dec; 38(6):3677-3684. PubMed ID: 29039555
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation.
Cheng D; Deng J; Zhang B; He X; Meng Z; Li G; Ye H; Zheng S; Wei L; Deng X; Chen R; Zhou J
EBioMedicine; 2018 Oct; 36():159-170. PubMed ID: 30195653
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1.
Zhang W; Kong G; Zhang J; Wang T; Ye L; Zhang X
PLoS One; 2012; 7(2):e31450. PubMed ID: 22319632
[TBL] [Abstract][Full Text] [Related]
14. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C
Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma.
Yang H; Zheng W; Shuai X; Chang RM; Yu L; Fang F; Yang LY
Oncotarget; 2015 Sep; 6(29):27736-50. PubMed ID: 26315541
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
[TBL] [Abstract][Full Text] [Related]
18. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
Quan H; Li B; Yang J
Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
